Trial Profile
A multicenter trial of fingolimod for the treatment of patients with multiple sclerosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 10 Dec 2015 New trial record